🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 8 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/11/2017 | 3,70 | 3,77 | 3,66 | 3,69 | -0,27% | 2,97% | 252.300 |
| 17/11/2017 | 3,62 | 3,87 | 3,62 | 3,70 | +3,06% | 6,91% | 657.500 |
| 16/11/2017 | 3,59 | 3,71 | 3,54 | 3,59 | +0,00% | 4,74% | 412.900 |
| 15/11/2017 | 3,51 | 3,68 | 3,42 | 3,59 | +0,84% | 7,41% | 358.000 |
| 14/11/2017 | 3,60 | 3,62 | 3,41 | 3,56 | -1,39% | 5,83% | 455.500 |
| 13/11/2017 | 3,64 | 3,70 | 3,54 | 3,61 | -1,90% | 4,40% | 322.800 |
| 10/11/2017 | 3,65 | 3,78 | 3,60 | 3,68 | +1,10% | 4,93% | 401.200 |
| 09/11/2017 | 3,52 | 3,72 | 3,51 | 3,64 | +1,39% | 5,82% | 482.500 |
| 08/11/2017 | 3,57 | 3,67 | 3,48 | 3,59 | +0,56% | 5,32% | 336.400 |
| 07/11/2017 | 3,70 | 3,72 | 3,53 | 3,57 | -2,72% | 5,14% | 280.800 |
| 06/11/2017 | 3,66 | 3,78 | 3,66 | 3,67 | -1,08% | 3,28% | 387.300 |
| 03/11/2017 | 3,50 | 3,75 | 3,49 | 3,71 | +4,21% | 7,43% | 583.500 |
| 02/11/2017 | 3,49 | 3,65 | 3,39 | 3,56 | +1,42% | 7,31% | 378.500 |
| 01/11/2017 | 3,65 | 3,70 | 3,46 | 3,51 | -3,57% | 6,58% | 373.400 |
| 31/10/2017 | 3,66 | 3,75 | 3,57 | 3,64 | -0,27% | 4,92% | 241.300 |
| 30/10/2017 | 3,65 | 3,73 | 3,55 | 3,65 | +0,00% | 4,93% | 313.400 |
| 27/10/2017 | 3,40 | 3,66 | 3,40 | 3,65 | +7,67% | 7,65% | 407.800 |
| 26/10/2017 | 3,75 | 3,75 | 3,30 | 3,39 | -9,36% | 12,00% | 1.035.200 |
| 25/10/2017 | 3,80 | 3,89 | 3,72 | 3,74 | -2,09% | 4,47% | 453.200 |
| 24/10/2017 | 3,88 | 3,95 | 3,80 | 3,82 | -1,80% | 3,74% | 418.200 |
| 23/10/2017 | 3,88 | 3,95 | 3,85 | 3,89 | +0,52% | 2,58% | 557.100 |
| 20/10/2017 | 4,02 | 4,07 | 3,86 | 3,87 | -3,25% | 5,22% | 669.700 |
| 19/10/2017 | 3,84 | 4,06 | 3,81 | 4,00 | +2,56% | 6,51% | 698.800 |
| 18/10/2017 | 3,97 | 3,97 | 3,72 | 3,90 | -0,51% | 6,30% | 511.800 |
| 17/10/2017 | 3,85 | 4,05 | 3,79 | 3,92 | +0,77% | 6,75% | 605.000 |
| 16/10/2017 | 4,00 | 4,05 | 3,73 | 3,89 | -2,75% | 8,00% | 714.200 |
| 13/10/2017 | 4,09 | 4,12 | 3,97 | 4,00 | -1,48% | 3,67% | 575.900 |
| 12/10/2017 | 4,11 | 4,15 | 3,98 | 4,06 | -0,98% | 4,14% | 476.400 |
| 11/10/2017 | 4,02 | 4,15 | 3,97 | 4,10 | +2,76% | 4,48% | 1.037.200 |
| 10/10/2017 | 4,44 | 4,44 | 3,94 | 3,99 | -8,49% | 11,26% | 1.927.100 |